The Heal in India announcement may have several pros and wins but being alert to the cons is even more potent. Cognizance of the impact on the overall approach towards the India healthcare model is crucial.
Is India ready to invite the world to ‘Heal in India’ or should it choose to focus on working to empower the nation’s healthcare ecosystem that continues to be crippled by its own shortcomings?, writes our Partner – Sidharrth Shankar in an article titled “Heal in India – The Hits” published in Express Pharma.
Please refer to the below document to read the full article by Sidharrth Shankar, published in Express Pharma.
Click here to download the pdf.
Sidharrth (Sid) is a seasoned corporate lawyer and also the co-chair of the corporate practice with a core focus on private equity and mergers & acquisitions. Sid has substantial experience advising global private equity funds, multinational corporations and strategic investors on complex cross-border transactions across a broad spectrum of industries over the last two and a half decades, with over two decades in JSA itself.